ACME’s asset value rises by Tk 800 million after revaluation
Logo
ACME Laboratories Limited, a pharmaceutical and chemical company listed on the stock market, has reported an increase of more than Tk 800 million in the value of its fixed assets following a revaluation. The net value of the company’s property, plant and equipment increased by Tk 803,193,206 after the revaluation. The company’s board of directors recently approved the revaluation.
The information was disclosed on Tuesday (October 27) through the websites of the Dhaka Stock Exchange (DSE) and the Chittagong Stock Exchange (CSE).
The company said its board of directors approved the revaluation report on property, plant and equipment at a meeting held on October 26. Chartered accountancy firm M M Rahman & Co. carried out the revaluation as an independent valuer. However, furniture and fixtures were excluded from the revaluation.
According to company information, the revaluation increased the value of fixed assets by Tk 812,869,698 as of June 30, 2026. Meanwhile, the value of certain assets decreased by Tk 9,676,492. Overall, the net value of the assets increased by Tk 803,193,206.
The company also said the surplus arising from the revaluation had been duly recorded in the financial statements for the financial year ended June 30, 2026.
According to relevant stakeholders, the revaluation of fixed assets may increase their book value in the company’s financial statements. However, this increase in asset value will not directly affect the company’s earnings or cash flow.
